Department of Health Care Policy, Harvard Medical School, Boston, MA.
Department of Economics, University of Rochester, Rochester, NY.
Am J Drug Alcohol Abuse. 2022 Sep 3;48(5):606-617. doi: 10.1080/00952990.2022.2072223. Epub 2022 Jun 6.
There is a striking geographic variation in drug overdose deaths without a specific drug recorded, many of which likely involve opioids. Knowledge of the reasons underlying this variation is limited. We sought to understand the role of medicolegal death investigation (MDI) systems in unclassified drug overdose mortality. This is an observational study of 2014 and 2018 fatal drug overdoses and U.S. county-level MDI system type (coroner vs medical examiner). Mortality data are from the CDC's National Center for Health Statistics. We estimated multivariable logistic regressions to quantify associations between MDI system type and several outcome variables: whether the drug overdose was unclassified and whether involvement of any opioid, synthetic opioid, methadone, and heroin was recorded (vs unclassified), for 2014 ( = 46,996) and 2018 ( = 67,359). In 2018, drug overdose deaths occurring in coroner counties were almost four times more likely to be unclassified (OR 3.87, 95% CI 2.32, 6.46) compared to medical examiner counties. These odds ratios are twice as large as in 2014 (difference statistically significant, < .001), indicating that medical examiner counties are improving identification of opioids in drug overdoses faster than coroner counties. Accurate reporting of drug overdose deaths depends on MDI systems. When developing state policies and local interventions aimed to decrease opioid overdose mortality, decision-makers should understand the role their MDI system is playing in underestimating the extent of the opioid overdose crisis. Improvements to state and county MDI systems are desirable if accurate reporting and appropriate policy response are to be achieved.
在没有记录特定药物的情况下,药物过量死亡存在显著的地域差异,其中许多可能涉及阿片类药物。对于导致这种差异的原因,我们知之甚少。我们试图了解法医死亡调查(MDI)系统在未分类药物过量死亡中的作用。这是一项对 2014 年和 2018 年致命药物过量和美国县级 MDI 系统类型(验尸官与法医)的观察性研究。死亡率数据来自疾病控制与预防中心国家卫生统计中心。我们估计多变量逻辑回归,以量化 MDI 系统类型与几个结果变量之间的关联:药物过量是否未分类,以及是否记录了任何阿片类药物、合成阿片类药物、美沙酮和海洛因(与未分类相比),2014 年( = 46996)和 2018 年( = 67359)。与法医县相比,2018 年在验尸官县发生的药物过量死亡几乎有四倍的可能性未被分类(OR 3.87,95%CI 2.32,6.46)。这些优势比在 2014 年增加了一倍(差异具有统计学意义, < .001),这表明法医县在识别药物过量中的阿片类药物方面的速度比验尸官县更快。药物过量死亡的准确报告取决于 MDI 系统。在制定旨在降低阿片类药物过量死亡率的州政策和地方干预措施时,决策者应该了解其 MDI 系统在低估阿片类药物过量危机程度方面所扮演的角色。如果要实现准确报告和适当的政策反应,就需要改进州和县级 MDI 系统。